Associated Papers
Red blood cell urate levels are linked to hemolysis in vitro and post-transfusion as a function of donor sex, population and genetic polymorphisms in SLC2A9 and ABCG2.
Key AM et al.
Transfusion, 2025
Evaluation of the Influence of Genetic Variants of SLC2A9 (GLUT9) and SLC22A12 (URAT1) on the Development of Hyperuricemia and Gout.
Pavelcova K et al.
Journal of Clinical Medicine, 2020
Amplicon targeted resequencing for SLC2A9 and SLC22A12 identified novel mutations in hypouricemia subjects.
Zhou Z et al.
Molecular Genetics & Genomic Medicine, 2019
31131560 (PubMed )
Supplement: MGG3-7-e00722-s002.xlsx › sheet_2
Genome sequencing analysis of blood cells identifies germline haplotypes strongly associated with drug resistance in osteosarcoma patients.
Bhuvaneshwar K et al.
Bmc Cancer, 2019
30991985 (PubMed )
Supplement: 12885_2019_5474_MOESM4_ESM.xlsx › 2016NovDec12_2016Dec12_85_15_GL
Discovery of URAT1 SNPs and association between serum uric acid levels and URAT1.
Cho SK et al.
Bmj Open, 2015
Absence of the SLC22A12 gene mutation in Turkish population with primary gout disease.
Yakut S et al.
Rheumatology International, 2013
Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and Idarubicin.
Iacobucci I et al.
The Pharmacogenomics Journal, 2013
Multiple single nucleotide polymorphisms in the human urate transporter 1 (hURAT1) gene are associated with hyperuricaemia in Han Chinese.
Li C et al.
Journal of Medical Genetics, 2010
Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)].
Xu G et al.
Kidney International, 2005
A high prevalence of renal hypouricemia caused by inactive SLC22A12 in Japanese.
Iwai N et al.
Kidney International, 2004
Select a paper to view details